Showing all 2 results


AM-2233 is a drug that acts as a highly potent full agonist for the cannabinoid receptors,with a Ki of 1.8 nM at CB1 and 2.2 nM at CB2 as the active (R) enantiomer.It was developed as a selective radioligand for the cannabinoid receptors and has been used as its 131I derivative for mapping the distribution of the CB1 receptor in the brain.AM-2233 was found to fully substitute for THC in rats, with a potency lower than that of JWH-018 but higher than WIN 55,212-2

Known to have similar effects to Tetrahydrocannabinol (THC), the active ingredient in Cannabis, this substance makes a great substitute for those wishing to undertake comparative studies.  A great deal of data can be drawn from just a small application of AM-2233, and it has primarily been used for mapping the CB1 receptor’s distribution.

AM-2233 is sold for research purposes only and is not be utilized for any other purposes.


Similar to the hallucinogenic DMT, AMT (a-Methyltryptamine) is a psychedelic stimulant that acts upon the serotonin receptor.

AMT is available in both powder and pellet form, and was developed in the 1960s as an anti-depressant. Effects include euphoria, heightened empathy towards others, and psychedelic awareness. provides AMT for the purposes of in vitro comparable research only. It is not available for human consumption.